Denali Ventures

Fanplayr is a prominent company specializing in online behavioral personalization and artificial intelligence, focused on enhancing user privacy. Headquartered in Palo Alto, California, with a global presence that includes offices in major cities across North America, South America, Europe, and Asia, Fanplayr offers a data analytics platform that provides real-time customer insights. This platform is designed to help businesses increase conversion rates and revenue by delivering personalized recommendations and improving lead collection. By leveraging analytic insights and targeting capabilities, Fanplayr enables companies to create engaging marketing campaigns that significantly boost conversion rates and positively impact their financial outcomes.

Gamida Cell Ltd., established in 1998 and headquartered in Jerusalem, Israel, is a clinical-stage biopharmaceutical company focused on developing advanced cell therapies to treat blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, is an expanded hematopoietic stem cell therapy derived from umbilical cord blood, currently in Phase 3 studies for patients with high-risk hematologic malignancies and severe aplastic anemia. Additionally, Gamida Cell is developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 trials for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Both candidates leverage the company's proprietary expansion platform based on nicotinamide to enhance cell properties and therapeutic potential.

Gamida Cell Ltd., established in 1998 and headquartered in Jerusalem, Israel, is a clinical-stage biopharmaceutical company focused on developing advanced cell therapies to treat blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, is an expanded hematopoietic stem cell therapy derived from umbilical cord blood, currently in Phase 3 studies for patients with high-risk hematologic malignancies and severe aplastic anemia. Additionally, Gamida Cell is developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 trials for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Both candidates leverage the company's proprietary expansion platform based on nicotinamide to enhance cell properties and therapeutic potential.

HyperRoll is a provider of data warehouse performance acceleration software that significantly enhances the efficiency of data management. Its flagship offering, the HyperRoll Data Performance Management Suite, improves load times, query times, and overall throughput for data warehouses, enabling organizations to respond quickly to changes in data and metadata. The suite is designed to reduce the total cost of ownership for data warehouses through its innovative software architecture. In addition to its core performance management solutions, HyperRoll also delivers a range of services including advisory, consulting, education, and technical support, catering to various sectors such as consumer products, retail, finance, supply chain, and customer relationship management.

D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions. The Company’s particular area of interest is in developing innovative medicine for degenerative and age-related disorders.

HyperRoll is a provider of data warehouse performance acceleration software that significantly enhances the efficiency of data management. Its flagship offering, the HyperRoll Data Performance Management Suite, improves load times, query times, and overall throughput for data warehouses, enabling organizations to respond quickly to changes in data and metadata. The suite is designed to reduce the total cost of ownership for data warehouses through its innovative software architecture. In addition to its core performance management solutions, HyperRoll also delivers a range of services including advisory, consulting, education, and technical support, catering to various sectors such as consumer products, retail, finance, supply chain, and customer relationship management.